Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.
The Approved Costing Guidance explains how NHS trusts should cost at patient level using the costing standards and then submit cost data for the financial year 2025/26 using the National Cost ...
FTAI Aviation's strategic capital initiative fund model underpins a robust, asset-light growth thesis. Read why FTAI stock is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results